Octilia eye drops 0.05% 8ml

Condition: New product

999 Items


More info

Active ingredients


Release form



On 1 ml: tetrizolina hydrochloride 500 mcg. Excipients: sodium hydrophosphate dodecahydrate, potassium dihydrophosphate, sodium chloride, disodium edetate, polysorbate 80, benzalkonium chloride, chamomile water, lime water, purified water.

Pharmacological effect

The drug with a vasoconstrictor action for local use in ophthalmology. Tetrizoline hydrochloride is an alpha adrenomimetic, an imidazole derivative. It has a pronounced vasoconstrictor effect, reduces swelling and hyperemia of the mucous membranes. Extracts of chamomile and linden have an anti-inflammatory effect.


When the local application of the recommended doses of the drug is absorbed slightly. Information about the degree of penetration into various tissues of the eye after local application is not.


As part of complex therapy in the treatment of eye diseases, accompanied by symptoms of irritation caused by allergic, chemical and physical factors (smoke, dust, strong illumination, reflection of light from snow and water surfaces, from radiating screens of monitors).


- glaucoma; - dry eye syndrome; - corneal epithelial-endothelial dystrophy; - children's age up to 3 years; - increased individual sensitivity to the components of the preparation.

Precautionary measures

With caution, you should prescribe the drug with an increase in blood pressure, coronary heart disease, arrhythmias, aneurysm, severe organic diseases of the heart and blood vessels, hyperthyroidism, pheochromocytoma, diabetes mellitus, during treatment with MAO inhibitors and other drugs that increase blood pressure, antidepressants during pregnancy and lactation ( breastfeeding).

Use during pregnancy and lactation

Precautions should be prescribed the drug Octyla during pregnancy and lactation (breastfeeding).

Dosage and administration

The drug is instilled 1-2 drops into the lower conjunctival sac 2-3 times / day.

Side effects

Local reactions: mydriasis, increased intraocular pressure, burning sensation, reactive conjunctival hyperemia. Systemic reactions: headache, nausea, drowsiness, weakness, tremor, dizziness, insomnia, palpitations, tachycardia, hyperglycemia, increased blood pressure, impaired heart activity, allergic reactions.


Symptoms: cyanosis, fever, convulsions, arrhythmias, cardiac arrest, increased blood pressure, pulmonary edema, dyspnea, CNS depression, accompanied by drowsiness, hypothermia, bradycardia, collapse, apnea, and coma. if swallowed. Treatment: The antidote is unknown. Assign activated carbon, gastric lavage, oxygen inhalation, antipyretic and antiepileptic drugs. To reduce blood pressure, phentolamine is prescribed at a dose of 5 mg slowly in / in or 100 mg orally.

Interaction with other drugs

Drug interaction of the drug Octilia is not described.

special instructions

The drug should not be used continuously for more than 4 days without consulting an ophthalmologist. If within 2 days the symptoms of the disease persist or become more pronounced, consultation with an ophthalmologist is necessary. The drug should be kept out of the reach of children, because if it is accidentally swallowed, the systemic action of the drug may develop. Patients using contact lenses should use Octilia only with lenses removed. Install lenses can be 15 minutes after instillation of the drug. The drug should not be used simultaneously with MAO inhibitors and for 10 days after stopping their administration.